Intelligence · Clinical Development
Pipeline search results
Programs matching “covid-19” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 147 pipeline programs matching "covid-19" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Casirivimab and Imdevimab Antibody Cocktail
Regeneron UK Limited
COVID-19
1 trial -
Experimental Vaccine 1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19 Pneumonia
1 trial -
Extracellular Vesicles from Mesenchymal Stem Cells
Regeneron Ireland Designated Activity Company (DAC)
COVID-19 Pneumonia
1 trial -
Galidesivir
Biocryst
COVID-19
1 trial -
INAVAC (Vaksin Merah Putih - UA- SARS CoV-2 (Vero Cell Inactivated) 5 μg
Hospital Authority, Hong Kong
COVID-19 Pandemic
1 trial -
IND165646
Lxo Ireland Designated Activity Company
Covid19
1 trial -
JSVCT098
Jiangsu Province Centers for Disease Control and Prevention
COVID-19
1 trial -
Lanadelumab
Takeda
COVID-19 Pneumonia
1 trial -
MSC-derived exosomes
Regeneron Ireland Designated Activity Company (DAC)
Long COVID-19 Syndrome
1 trial -
MSCs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
Nezulcitinib (TD-0903) Dose A
Theravance Biopharma Ireland Umited
Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)
1 trial -
Protrans V
Lacuna Pharma Pty Ltd
Respiratory viral disease, COVID-19, Influenza A, Metapneumovirus, Respiratory syncytial virus Infection
1 trial -
Q-Griffithsin
United Therapeutics Europe Ltd
COVID-19 Prevention
1 trial -
Q-Griffithsin 3.0
United Therapeutics Europe Ltd
COVID-19 Prevention
1 trial -
QLS1128 A-Dose 1~5 and Ritonavir
Qilu Pharmaceutical (Hainan) Co.,
COVID-19
1 trial -
REC611-IIT-1
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prevention of COVID-19 Caused by SARS-CoV-2
1 trial -
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
SA55 Injection
Sinovac Research and Development Co.,
COVID-19
1 trial -
SA55 nasal spray
Sinovac Research and Development Co.,
COVID-19
1 trial -
SAB-185
SAB Biotherapeutics
COVID-19
2 trials -
Sotrovimab
Vir Biotechnology
COVID-19 Infection
1 trial -
TI-0010
BRIGHT MINDS BIOSCIENCES INC.
COVID-19
1 trial -
Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
Hospital Authority, Hong Kong
COVID-19 Pandemic
1 trial -
AZD1222
AstraZeneca
COVID-19, SARS-CoV-2
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.